First Page | Document Content | |
---|---|---|
Date: 2014-04-30 06:24:54Pharmacology Pharmaceuticals policy Science Pharmaceutical industry Clinical research Compounding Good manufacturing practice Qualified Person Barrier isolator Pharmaceutical sciences Pharmacy Health | (H-PIC\S) Version 1.0 November 2013 Developed by: Working group of the HPAI Aseptic Services Special Interest Group (ASSIG)Add to Reading ListSource URL: www.hpai.ieDownload Document from Source WebsiteFile Size: 272,25 KBShare Document on Facebook |
JCAMECH Vol. 49, No. 1, June 2018, ppDOI: jcamechEffect of nano-structuration and compounding of YSZ APS TBCs with different thickness on coating performance in thermal shockDocID: 1vbK0 - View Document | |
ALABAMA STATE BOARD OF PHARMACY NOTICE OF INTENDED ACTION RULE NUMBER: 680-XTITLE OF RULE: REOUIREMENTS FOR COMPOUNDING 680-X-2-.43DocID: 1uhGB - View Document | |
Evaluation of Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act Guidance for IndustryDocID: 1tBOU - View Document | |
data sheet Compounding CS 122Y-14P Chopped Strand for PC & PPODocID: 1syCN - View Document | |
data sheet Compounding DS8800-11P Chopped Strand for high T PlasticsDocID: 1rQMk - View Document |